Laboratory Studies
Laboratory studies are nonspecific and generally not helpful. The white blood cell (WBC) count is mildly depressed (mean, approximately 3900/µL) in about 66% of patients. Leukopenia may suggest the diagnosis. Rarely, thrombocytopenia occurs. Occasionally, patients with Colorado tick fever have elevated hepatic transaminase levels (in the mid-hundreds).
Analysis of cerebrospinal fluid (CSF) analysis may demonstrate mild-to-moderate lymphocytic pleocytosis (up to 300 cells/µL) and mildly elevated protein levels.
Because the clinical features of Colorado tick fever are nonspecific, the diagnosis must be established in the proper epidemiologic context. Confirmation is based on serologic test results or virus inoculation in mice. In addition, reverse transcriptase polymerase chain reaction (PCR) techniques are available that may help diagnose the disease in the first 5 days of illness.
Neutralizing antibodies appear in about one third of cases by day 10 and in nearly all patients by 1 month after infection. A 4-fold increase in titers between specimens drawn during the acute phase and those drawn during convalescence is observed in nearly all patients. The assay, performed with complement fixation or immunofluorescent techniques, must be done in a laboratory that has experience with this test.
Antibodies to the Colorado tick virus frequently are found in perennial campers who frequent endemic areas; thus, a single elevated titer of immunoglobulin G (IgG) does not necessarily indicate acute infection. This finding also suggests asymptomatic seroconversion.
Although viral testing is not routinely available, the virus can be detected in the blood for 2-4 weeks after infection. Laboratory techniques also allow isolation of RNA and DNA from the tick itself to detect bacterial and viral pathogens; coinfection is a possibility.[7]
Spruance SL, Bailey A. Colorado Tick Fever. A review of 115 laboratory confirmed cases. Arch Intern Med. Feb 1973;131(2):288-93. [Medline].
Klasco R. Colorado tick fever. Med Clin North Am. Mar 2002;86(2):435-40, ix. [Medline].
Emmons RW. Ecology of Colorado tick fever. Annu Rev Microbiol. 1988;42:49-64. [Medline].
Leiby DA, Gill JE. Transfusion-transmitted tick-borne infections: a cornucopia of threats. Transfus Med Rev. Oct 2004;18(4):293-306. [Medline].
Romero JR, Simonsen KA. Powassan encephalitis and colorado tick fever. Infect Dis Clin North Am. Sep 2008;22(3):545-59, x. [Medline].
Goodpasture HC, Poland JD, Francy DB, et al. Colorado tick fever: clinical, epidemiologic, and laboratory aspects of 228 cases in Colorado in 1973-1974. Ann Intern Med. Mar 1978;88(3):303-10. [Medline].
Crowder CD, Rounds MA, Phillipson CA, et al. Extraction of total nucleic acids from ticks for the detection of bacterial and viral pathogens. J Med Entomol. Jan 2010;47(1):89-94. [Medline]. [Full Text].
Wilson ME. Prevention of tick-borne diseases. Med Clin North Am. Mar 2002;86(2):219-38. [Medline].

